Rivastigmine reduces "likely to use methamphetamine" in methamphetamine-dependent volunteers

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 37, Issue 1, 2012, Pages 141-146

  De La Garza, R ^a   Newton, T F ^a   Haile, C N ^a   Yoon, J H ^a   Nerumalla, C S ^a   Mahoney, J J ^a   Aziziyeh, A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acetylcholine; Addiction; Methamphetamine; Rivastigmine; Treatment

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; METHAMPHETAMINE; PLACEBO; RIVASTIGMINE; SODIUM CHLORIDE;

ADULT; ARTICLE; CHOLINESTERASE INHIBITION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG CHOICE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SELECTIVITY; DRUG SELF ADMINISTRATION; EVENING DOSAGE; FEMALE; HUMAN; INTRAVENOUS ADMINISTRATION; MALE; MORNING DOSAGE; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; SHORT COURSE THERAPY; SMOKING; UNSPECIFIED SIDE EFFECT; VOLUNTEER;

ADULT; AMPHETAMINE-RELATED DISORDERS; BEHAVIOR, ADDICTIVE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHAMPHETAMINE; PHENYLCARBAMATES;

EID: 84857782772     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.12.014     Document Type: Article

References (30)

1. Adinoff B., Devous M.D., Williams M.J., Best S.E., Harris T.S., Minhajuddin A., et al. Altered neural cholinergic receptor systems in cocaine-addicted subjects. Neuropsychopharmacology 2010, 35:1485-1499.
2. De La Garza R., Yoon J.H. Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1827-1830.
3. De La Garza R., Mahoney J.J., Culbertson C., Shoptaw S., Newton T.F. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav 2008, 89:200-208.
4. De La Garza R., Shoptaw S., Newton T.F. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol 2008, 1-13.
5. Desai R.I., Bergman J. Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds. J Pharmacol Exp Ther 2010, 335:807-816.
6. Elkashef A., Vocci F., Hanson G., White J., Wickes W., Tiihonen J. Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 2008, 29:31-49.
7. Gatch M.B., Flores E., Forster M.J. Nicotine and methamphetamine share discriminative stimulus effects. Drug Alcohol Depend 2008, 93:63-71.
8. Grasing K, Mathur D, Newton TF, DeSouza C. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug Alcohol Depend.107:69-75.
9. Haile C.N., Kosten T.R., Kosten T.A. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse 2009, 35:161-177.
10. Haney M., Spealman R. Controversies in translational research: drug self-administration. Psychopharmacology 2008, 199:403-419.
11. Hiranita T., Nawata Y., Sakimura K., Anggadiredja K., Yamamoto T. Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proc Natl Acad Sci U S A 2006, 103:8523-8527.
12. Hurd Y.L., Weiss F., Koob G., Ungerstedt U. The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci Lett 1990, 109:227-233.
13. Kampman K.M. The search for medications to treat stimulant dependence. Addict Sci Clin Pract 2008, 4:28-35.
14. Karila L., Weinstein A., Aubin H.J., Benyamina A., Reynaud M., Batki S.L. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 2010, 69:578-592.
15. Kish S.J., Kalasinsky K.S., Furukawa Y., Guttman M., Ang L., Li L., et al. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Mol Psychiatry 1999, 4:26-32.
16. Mark G.P., Hajnal A., Kinney A.E., Keys A.S. Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology 1999, 143:47-53.
17. Mark G.P., Kinney A.E., Grubb M.C., Keys A.S. Involvement of acetylcholine in the nucleus accumbens in cocaine reinforcement. Ann N Y Acad Sci 1999, 877:792-795.
18. Moeller F.G., Schmitz J.M., Herin D., Kjome K.L. Use of stimulants to treat cocaine and methamphetamine abuse. Curr Psychiatry Rep 2008, 10:385-391.
19. Neugebauer N.M., Harrod S.B., Bardo M.T. Nicotine elicits methamphetamine-seeking in rats previously administered nicotine. Drug Alcohol Depend 2010, 106:72-78.
20. Plebani JG, Lynch KG, Yu Q, Pettinati HM, O'Brien CP, Kampman KM. Results of an initial clinical trial of varenicline for the treatment of cocaine dependence. Drug Alcohol Depend (in press). PMID: 21925806.
21. Rose M.E., Grant J.E. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry 2008, 20:145-155.
22. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 2003, 168:3-20.
23. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33. [quiz 4-57].
24. Shen X.Y., Orson F.M., Kosten T.R. Vaccines against drug abuse. Clin Pharmacol Ther 2012, 91:60-70.
25. Siegal D., Erickson J., Varoqui H., Ang L., Kalasinsky K.S., Peretti F.J., et al. Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse 2004, 52:223-232.
26. Stoops W.W., Lile J.A., Rush C.R. Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol Biochem Behav 2010, 95:187-191.
27. Vocci F.J., Appel N.M. Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 2007, 102(Suppl. 1):96-106.
28. Williams M.J., Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008, 33:1779-1797.
29. Witten I.B., Lin S.C., Brodsky M., Prakash R., Diester I., Anikeeva P., et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 2010, 330:1677-1681.
30. Zorick T., Sevak R.J., Miotto K., Shoptaw S., Swanson A.N., Clement C., et al. Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J Exp Pharmacol 2009, 2010:13-18.